Complete Filing Data
MEDICURE INC reported Diluted Earnings Loss Per Share of 0 shares for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean MEDICURE INC did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Research And Development Expense | $3.1M | $2.4M | $2.8M | $1.8M | $3.3M | $4.3M | $6.7M | $5.1M | $3.6M | $4.9M |
| Profit Loss Before Tax | -$783.0K | -$897.0K | $1.4M | -$759.0K | -$6.8M | -$19.6M | $4.8M | $2.4M | $3.8M | $1.3M |
| Profit Loss | -$1.0M | -$922.0K | $1.4M | -$727.0K | -$6.8M | -$19.8M | $3.9M | $43.4M | $27.0M | $1.7M |
| Other Comprehensive Income | $1.7M | -$531.0K | $1.2M | -$143.0K | -$746.0K | -$7.0M | $595.0K | -$9.0K | -$422.4K | $806.1K |
| Gross Profit | $13.1M | $14.0M | $16.1M | $12.7M | $5.1M | $12.9M | $25.0M | $23.7M | $25.6M | $19.8M |
| Cost Of Sales | $8.8M | $7.7M | $7.0M | $9.0M | $6.5M | $7.3M | $4.2M | $3.5M | $3.7M | $2.3M |
| Comprehensive Income | $686.0K | -$1.5M | $2.5M | -$870.0K | -$7.6M | -$26.8M | $4.5M | $43.4M | $26.6M | $2.5M |
| Profit Loss From Continuing Operations | -$1.0M | -$922.0K | $1.4M | -$727.0K | -$6.8M | -$19.8M | $3.9M | $11.5M | $3.6M | $1.7M |
| Income Tax Expense Continuing Operations | -$256.0K | -$25.0K | -$20.0K | $32.0K | $0.00 | $145.0K | $897.0K | -$9.1M | $170.2K | |
| Income Taxes Paid Refund Classified As Operating Activities | $177.0K | $61.0K | $91.0K | $0.00 | $306.0K | $477.0K | $2.0M | $894.0K | ||
| General And Administrative Expense | $4.8M | $4.1M | $4.2M | $2.7M | $4.6M | $3.4M | $3.9M | $3.4M | ||
| Current Income Tax Recovery Expense | $256.0K | $25.0K | $20.0K | -$32.0K | $22.0K | $678.0K | -$9.4M | $504.6K | ||
| Deferred Income Tax Recovery Expense | $123.0K | $219.0K | -$1.5M | $301.5K | -$379.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $7.2M | $6.4M | $4.9M | $3.7M | $2.7M | $13.0M | $24.1M | $5.3M | $12.3M | $3.6M | $493.9K |
| Cash Flows From Used In Operating Activities | $1.4M | $2.1M | $1.8M | $4.0M | -$2.2M | -$14.6M | $742.0K | $21.9M | $6.4M | $142.8K | |
| Cash Flows From Used In Investing Activities | -$739.0K | -$270.0K | -$310.0K | -$2.7M | -$7.2M | $34.3M | $19.7M | $54.2M | -$42.2M | -$226.6K | |
| Cash Flows From Used In Financing Activities | -$370.0K | -$297.0K | -$355.0K | -$316.0K | -$766.0K | -$30.3M | -$2.7M | -$83.0M | $44.5M | $3.1M | |
| Amortisation Intangible Assets Other Than Goodwill | $1.9M | $1.7M | $1.6M | $2.7M | $2.5M | $1.4M | $196.0K | $6.6M | $2.2M | $659.4K | |
| Adjustments For Decrease Increase In Trade Account Receivable | $150.0K | $760.0K | -$864.0K | $593.0K | $5.1M | -$318.0K | -$1.3M | -$3.7M | -$4.2M | -$8.2M | |
| Increase Decrease Through Foreign Exchange And Other Movements Financial Assets | $71.0K | $108.0K | -$52.0K | -$31.0K | -$497.0K | $362.0K | -$5.3M | $271.0K | $215.4K | $111.8K | |
| Depreciation Property Plant And Equipment | $438.0K | $434.0K | $461.0K | $406.0K | $307.0K | $485.0K | $103.0K | $1.2M | $189.0K | $31.5K | |
| Adjustments For Increase Decrease In Trade Account Payable And Accrued Liabilities | -$494.0K | -$236.0K | $568.0K | $20.0K | -$3.8M | -$5.0M | $7.1M | $48.4M | $143.3K | $4.6M | |
| Adjustments For Decrease Increase In Other Operating Receivables | $237.0K | -$26.0K | -$194.0K | $305.0K | $703.0K | $842.0K | -$1.8M | $77.0K | $1.7M | -$1.1M | |
| Deferred Tax Expense Income | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $123.0K | $219.0K | $333.0K | -$331.1K | -$379.0K | |
| Purchase Of Intangible Assets Classified As Investing Activities | $739.0K | $270.0K | $296.0K | $441.0K | $13.7M | $1.3M | $127.0K | ||||
| Trade And Other Current Receivables | $5.3M | $4.8M | $5.6M | $4.7M | $5.3M | $10.2M | $10.8M | $8.6M | $17.2M | ||
| Trade And Other Current Payables | $7.9M | $7.6M | $7.1M | $6.7M | $7.0M | $9.4M | $14.4M | $10.4M | $17.9M | ||
| Retained Earnings | -$66.9M | -$65.9M | -$64.9M | -$66.3M | -$65.6M | -$62.6M | -$50.1M | -$54.5M | -$98.0M | ||
| Property Plant And Equipment | $955.0K | $736.0K | $1.2M | $1.6M | $1.6M | $1.3M | $316.0K | $221.6K | $10.3M | ||
| Noncurrent Liabilities | $506.0K | $229.0K | $503.0K | $1.5M | $2.6M | $3.7M | $3.2M | $4.5M | $114.9M | ||
| Noncurrent Assets | $13.8M | $12.9M | $15.1M | $15.9M | $18.4M | $10.9M | $14.2M | $14.4M | $159.5M | ||
| Liabilities | $8.9M | $8.2M | $8.9M | $10.0M | $14.9M | $15.3M | $20.2M | $48.2M | $176.4M | ||
| Intangible Assets Other Than Goodwill | $9.4M | $8.9M | $10.6M | $11.2M | $13.6M | $9.6M | $1.7M | $1.8M | $100.9M | ||
| Equity And Liabilities | $29.7M | $28.1M | $29.9M | $28.4M | $34.1M | $42.3M | $103.8M | $128.9M | $214.7M | ||
| Current Tax Liabilities Current | $95.0K | $16.0K | $60.0K | $114.0K | $164.0K | $517.0K | $1.1M | $2.4M | $504.6K | ||
| Current Liabilities | $8.4M | $7.9M | $8.4M | $8.5M | $12.3M | $11.7M | $16.9M | $43.7M | $61.6M | ||
| Current Assets | $15.9M | $15.2M | $14.8M | $12.6M | $15.7M | $31.4M | $89.6M | $114.6M | $55.2M | ||
| Assets | $29.7M | $28.1M | $29.9M | $28.4M | $34.1M | $42.3M | $103.8M | $128.9M | $214.7M | ||
| Acquisitions Of Property Plant And Equipment | $0.00 | $0.00 | $14.0K | $377.0K | $2.0K | $186.0K | $197.0K | $1.2M | |||
| Accumulated Other Comprehensive Income | -$4.3M | -$6.0M | -$5.5M | -$6.6M | -$6.5M | -$5.8M | $1.3M | $673.3K | $682.0K | ||
| Goodwill | $3.4M | $3.1M | $3.2M | $3.0M | $3.0M | $0.00 | $47.5M | ||||
| Adjustments For Decrease Increase In Other Assets | -$18.0K | $0.00 | -$2.0K | $99.0K | $78.0K | $33.0K | -$1.2K | ||||
| Other Noncurrent Assets | $98.0K | $75.0K | $63.0K | $57.0K | $156.0K | $39.0K | $117.0K | $161.9K | |||
| Current Contract Liabilities | $0.00 | $179.0K | $423.0K | $362.0K | $872.0K | $1.5M | $1.5M | $2.0M | |||
| Noncurrent Lease Liabilities | $506.0K | $229.0K | $503.0K | $789.0K | $1.1M | $849.0K | |||||
| Current Lease Liabilities | $368.0K | $315.0K | $346.0K | $380.0K | $367.0K | $240.0K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $7.2M | $6.4M | $4.9M | $3.7M | $2.7M | ||||||
| Noncurrent Contract Liabilities | $65.0K | $335.0K | $1.2M | $2.0M | $2.9M | $3.7M | |||||
| Revaluation Of Holdback Receivable | $3.6M | $1.5M | -$83.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Cash And Cash Equivalents | $822.0K | $1.5M | $1.2M | $978.0K | -$10.2M | -$11.2M | $18.9M | -$7.0M | $8.7M | $3.1M |
| Payments Of Lease Liabilities Classified As Financing Activities | $370.0K | $353.0K | $355.0K | $316.0K | $244.0K | $102.0K | ||||
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | $554.0K | $0.00 | $0.00 | -$1.0K | -$3.0K | -$552.0K | $1.1M | |||
| Proceeds From Exercise Of Options | $20.0K | $363.0K | $520.0K | $1.8M | $33.2K | |||||
| Payments To Acquire Or Redeem Entitys Shares | 0.00 | 522.0K | 4.1M | 3.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Diluted Earnings Loss Per Share | $-0.10 | $-0.09 | $0.13 | $-0.07 | $-0.64 | $-1.32 | $0.24 | $2.39 | $1.56 | $0.11 |
| Basic Earnings Loss Per Share | $-0.10 | $-0.09 | $0.13 | $-0.07 | $-0.64 | $-1.32 | $0.25 | $2.78 | $1.80 | $0.12 |
| Diluted Earnings Loss Per Share From Continuing Operations | $-1.32 | $0.24 | $0.63 | $0.21 | $0.11 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Reclassification Adjustments On Exchange Differences On Translation Net Of Tax | -$1.7M | $531.0K | -$1.2M | $143.0K | $746.0K | $683.0K | -$595.0K | $30.0K | $400.8K | -$806.1K |
| Operating Expense | $15.8M | $14.8M | $14.9M | $14.8M | $13.2M | $21.1M | $26.2M | $20.0M | $19.0M | $15.1M |
| Increase Decrease Through Transactions With Owners | $196.0K | $344.0K | $47.0K | $135.0K | -$205.0K | -$29.8M | -$1.6M | $1.1M | $5.2M | $5.9M |
| Increase Decrease Through Sharebased Payment Transactions | $196.0K | $288.0K | $47.0K | $135.0K | $317.0K | $417.0K | $1.0M | $491.0K | $1.3M | $1.5M |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | -$71.0K | -$108.0K | $52.0K | -$31.0K | -$497.0K | $2.6M | -$6.5M | $175.0K | -$262.5K | -$68.8K |
| Adjustments For Sharebased Payments | $196.0K | $288.0K | $47.0K | $135.0K | $317.0K | $417.0K | $1.0M | $623.0K | $1.4M | $1.5M |
| Adjustments For Decrease Increase In Inventories | -$207.0K | -$31.0K | $166.0K | $471.0K | $723.0K | -$4.1M | -$1.3M | $145.0K | $2.5M | -$1.2M |
| Current Tax Expense Income | -$256.0K | -$25.0K | -$20.0K | -$32.0K | $0.00 | $22.0K | $678.0K | -$9.4M | $501.3K | |
| Writedowns Reversals Of Inventories | $78.0K | $277.0K | $38.0K | $1.3M | $682.0K | $2.0M | $95.0K | $385.0K | -$108.8K | $40.9K |
| Royalties Paid Classified As Operating Activities | $0.00 | -$256.0K | -$1.1M | -$99.0K | -$326.0K | -$1.4M | -$1.5M | -$1.8M | -$1.7M | -$642.8K |
| Finance Costs Including Foreign Exchange Gain Loss | -$94.0K | $43.0K | $154.0K | -$494.0K | $1.3M | -$1.5M | $7.5M | $662.0K | $2.7M | $4.2M |
| Finance Income Cost | $165.0K | $65.0K | -$206.0K | $525.0K | -$765.0K | -$1.1M | -$1.1M | -$837.0K | -$2.5M | |
| Interest Paid Received Classified As Operating Activities | $175.0K | $48.0K | -$16.0K | -$49.0K | -$22.0K | -$1.7M | -$255.0K | $7.5M | $1.2M | |
| Selling Expense | $8.0M | $8.3M | $7.9M | $10.3M | $5.4M | $13.4M | $15.6M | $11.5M | ||
| Adjustments For Finance Income Cost | -$165.0K | -$65.0K | $190.0K | -$525.0K | $765.0K | $1.1M | $1.1M | -$837.0K | ||
| Issued Capital | $81.0M | $81.0M | $80.9M | $80.9M | $80.9M | $85.4M | $122.9M | $125.7M | $124.7M | |
| Current Prepaid Expenses | $126.0K | $1.1M | $1.1M | $869.0K | $1.2M | $1.9M | $2.7M | $903.9K | $759.1K | |
| Share Premium | $10.9M | $10.7M | $10.5M | $10.4M | $10.3M | $8.0M | $7.6M | $6.9M | $6.8M | |
| Inventories Total | $3.3M | $2.9M | $3.2M | $3.3M | $5.1M | $6.3M | $4.2M | $3.1M | $12.2M | |
| Increase Decrease Through Exercise Of Options | $56.0K | $20.0K | $363.0K | $520.0K | $1.8M | $33.2K | ||||
| Other Expense Income | -$1.9M | $0.00 | -$346.0K | -$1.8M | $9.9M |
Most recent annual filing with the SEC: April 25, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.